Harpoon Therapeutics, Inc. - Common Stock (NQ:HARP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Mar 8, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harpoon Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline

January 08, 2024

From Merck & Co., Inc.

Via Business Wire

Why Is Cancer Focused Harpoon Therapeutics Stock Shooting Higher Today? ↗

January 08, 2024

Merck & Co Inc (NYSE: MRK) is reportedly negotiating to purchase cancer drugmaker Harpoon Therapeutics Inc (NASDAQ:

Via Benzinga

Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

January 08, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading....

Via Benzinga

Topics Stocks

Harpoon Therapeutics Strengthens Leadership Team

December 26, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Expert Ratings for Harpoon Therapeutics ↗

December 13, 2023

Via Benzinga

Harpoon Therapeutics Abstract for HPN328 Accepted for Rapid Oral Presentation at the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium

December 19, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)

December 11, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 27, 2023

Via Benzinga

Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 09, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Harpoon Therapeutics Abstract for HPN217 Accepted for Presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition

November 02, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Why Biophytis Shares Are Trading Higher By Over 12%: Here Are 20 Stocks Moving Premarket ↗

October 30, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 30, 2023

It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!

Via InvestorPlace

Why Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday.

Via Benzinga

What's Going On With Harpoon Therapeutics Stock Monday? ↗

October 23, 2023

Harpoon Therapeutics Inc (NASDAQ: HARP) shares are trading higher Monday after the company announced updated data from a trial evaluating&n

Via Benzinga

Why Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 23, 2023

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set...

Via Benzinga

Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 23, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 23, 2023

It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!

Via InvestorPlace

Harpoon Therapeutics Announces Up to $150 Million Private Placement

October 23, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Harpoon Therapeutics Announces Updated Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023

October 21, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 19, 2023

We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 18, 2023

Via Benzinga

Harpoon Therapeutics Inc. (NASDAQ: HARP) Leading the Way in Wednesday Trading Based on Percentage Gain

October 18, 2023

Via Investor Brand Network

Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023

October 16, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 13, 2023

Via Benzinga

Harpoon Therapeutics to Present Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023

October 09, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Harpoon Therapeutics Presents HPN217 Interim Phase 1 Data at the IMS Annual Meeting

September 28, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

Harpoon Therapeutics Announces First Patients with Small Cell Lung Cancer Dosed in HPN328 Combination Cohort

September 15, 2023

From Harpoon Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 14, 2023

Via Benzinga

Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2023

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.

Via Benzinga

Why Is Immuno-Oncology Firm Harpoon Therapeutics Stock Trading Lower Today? ↗

September 14, 2023

Harpoon Therapeutics Inc (NASDAQ: HARP) shares are trading lower after AbbVie Inc (NYSE: ABBV) chose not to exercise its exclusive license option within the Development and Option Agreement...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.